Zenas BioPharma, Inc. (ZBIO) stock analysis

In our weekly check, Zenas BioPharma, Inc. is graded D (A to F). Of 19 checks on debt, profit, cash flow and trend: 7 pass, warnings: 2, red flags: 10.

About Zenas BioPharma, Inc.

Zenas BioPharma, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ZBIO.

What our checks show for ZBIO

Red flags

Warning signs

Strengths

Similar companies

AGIO · FTRE · MAZE · TRVI · BCRX

Questions

What grade does Zenas BioPharma, Inc. (ZBIO) have?

In our weekly check, Zenas BioPharma, Inc. is graded D (A to F). Of 19 checks on debt, profit, cash flow and trend: 7 pass, warnings: 2, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ZBIO stock?

This week's biggest flags for Zenas BioPharma, Inc.: High debt, Weak interest cover, Weak EPS forecast. In total 12 of 19 checks show a warning or a red flag.

What does Zenas BioPharma, Inc. do?

Zenas BioPharma, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ZBIO.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis